相关实验视频

Updated: Jan 9, 2026

Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations

Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations

Published on: October 20, 2017

梅特福林用于治疗未破裂的脊基底剖析动脉瘤 (METTLE):一项双盲随机对照试验的研究方案

Linggen Dong^1,2, Ziming Xu³, Yan Li³

¹Department of Interventional Neuroradiology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China.

|December 6, 2025

概括

这项临床试验调查了甲福明是否可以降低脊基解剖动脉瘤 (VBDA) 的炎症. 这项研究旨在评估甲胺.

科学领域:

神经学神经学
心血管研究研究心血管研究
药理学药理学是指药理学的学科.

背景情况:

脊髓底剖析动脉瘤 (VBDA) 是中风的重要原因,死亡率高.
动脉瘤壁炎症是VBDA生长和破裂的关键因素.
梅特福明因其抗炎性质而闻名,是VBDA的潜在治疗剂.

研究的目的:

评估甲福明在减少VBDA壁炎症方面的有效性.
评估甲胺对VBDA形态和炎症标志物的影响.

主要方法:

一个多中心的,前性的,随机的,受控的,盲目的临床试验.
60名未破裂的VBDA患者将随机分配给接受甲福明或安慰剂六个月.
高分辨率血管壁成像 (HR-VWI) 将测量动脉瘤壁炎症的变化.

主要成果:

主要结局:通过HR-VWI改变VBDA壁炎症.
二次结果:VBDA形态的变化,成像征兆和炎症生物标志物.

结论:

这项研究解决了关于甲福明治疗内动脉瘤的人类临床数据的缺乏问题.
研究结果可能会揭示甲福明作为未破裂的VBDA的新疗法,可能会抑制生长和破裂.
结果将通过出版物和会议传播.

关键词:

高分辨率的血管壁成像.炎症反应是一种炎症反应.甲胺是一种甲胺.随机对照试验是随机对照试验.脊髓基解剖动脉瘤的发生.

更多相关视频

Author Spotlight: Methodologies and Advancements of Chronic Pain Management Research

Author Spotlight: Methodologies and Advancements of Chronic Pain Management Research

Published on: January 5, 2024

Minimally Invasive Thumb-sized Pterional Craniotomy for Surgical Clip Ligation of Unruptured Anterior Circulation Aneurysms

Minimally Invasive Thumb-sized Pterional Craniotomy for Surgical Clip Ligation of Unruptured Anterior Circulation Aneurysms

Published on: August 11, 2015

相关概念视频

Oral Hypoglycemic Agents: Biguanides and Glitazones

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...

Blinding

Blinding

Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.